Schwab U.S. Dividend Equity vs. Vanguard Dividend Appreciation: Which ETF Looks Better for Your Portfolio?

The Schwab U.S. Dividend Equity ETF (NYSEMKT:SCHD) offers a higher current yield and deeper value tilt, whereas the Vanguard Dividend Appreciation ETF (NYSEMKT:VIG) focuses on consistent dividend growth and tech-heavy quality.

Both funds target dividend-paying companies, but their underlying methodologies lead to distinct portfolio profiles. The Schwab fund screens for sustainable high yields and fundamental financial strength, while the Vanguard fund strictly requires a 10-year track record of annual dividend increases. This difference creates a more conservative, tech-forward tilt for the Vanguard fund versus the value focus of its peer.

Snapshot (cost & size)

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Both funds offer extremely affordable expense ratios. The primary differentiator for many income investors is the significant yield difference, with the Schwab fund nearly doubling the payout of its Vanguard peer.

Performance & risk comparison

What's inside

The Schwab U.S. Dividend Equity ETF aims to track the overall performance of the Dow Jones U.S. Dividend 100 Index, which filters for companies with high yields and consistent payment histories. This investment strategy results in a portfolio of 102 holdings that concentrates on healthcare at 21%, consumer defensive at 20%, and energy at 15%. Its largest positions include Merck (NYSE:MRK) at 4.92%, Abbott Laboratories (NYSE:ABT) at 4.83%, and Amgen (NASDAQ:AMGN) at 4.8%. Launched in 2011, SCHD has paid $1.05 per share over the trailing 12 months.

The Vanguard Dividend Appreciation ETF seeks to track the S&P U.S. Dividend Growers Index by focusing on companies that have increased their annual payouts for at least 10 consecutive years. This methodology results in a 333-holding portfolio led by technology at 26%, financial services at 22%, and healthcare at 18%. Top holdings include Broadcom (NASDAQ:AVGO) at 4.63%, Apple (NASDAQ:AAPL) at 4.45%, and Microsoft (NASDAQ:MSFT) at 4.34%. Launched in 2006, VIG has paid $3.58 per share over the trailing 12 months.

For more guidance on ETF investing, check out the full guide at this link.

Which looks like the better buy?

Both of these ETFs are likely very appealing to income investors. SCHD may have a slightly higher expense ratio, but I don't think it's worth quibbling over a 2-basis-point difference. Their assets under management are in the same ballpark, with VIG being a bit larger. However, SCHD has much higher average trading volume, which suggests greater liquidity. Vanguard's one-year return trails Schwab's, but the ETFs are pretty closely matched when it comes to five-year returns.

I would say the two key differentiators are the portfolio composition and yield. VIG holds over 300 stocks, while SCHD has about 100. Neither ETF has a position that exceeds a 5% weighting, which I generally find attractive from a risk perspective. VIG has greater diversification on the face of it, but its top three holdings are multitrillion-dollar tech companies, which presents some concentration risk.

Finally, the yield: Schwab's fund pays out nearly twice as much as Vanguard's does. All else equal, I think SCHD's value bent and higher yield make it the better buy.

Erin Kennedy has positions in Apple, Schwab U.S. Dividend Equity ETF, and Vanguard Dividend Appreciation ETF. The Motley Fool has positions in and recommends Abbott Laboratories, Amgen, Apple, Broadcom, Merck, Microsoft, and Vanguard Dividend Appreciation ETF. The Motley Fool has a disclosure policy.